Drug Type Small molecule drug |
Synonyms (1S)-1,4-dideoxy-4-imino-(9-deazahypoxanthin-9-yl)-D-ribitol, 1,4-Dideoxy-4-aza-1-(S)-(9-deazahypoxanthin-9-yl)-D-ribitol, FDS + [10] |
Target |
Action inhibitors |
Mechanism PNP inhibitors(Purine nucleoside phosphorylase inhibitors), Immunosuppressants |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (31 Mar 2017), |
RegulationOrphan Drug (European Union), Orphan Drug (Japan) |
Molecular FormulaC11H15ClN4O4 |
InChIKeyWEIAMZKHBCLFOG-QPAIBFMUSA-N |
CAS Registry284490-13-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04245 | Forodesine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Peripheral T-Cell Lymphoma | Japan | 31 Mar 2017 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pre B-cell acute lymphoblastic leukemia | Phase 2 | Austria | 01 Mar 2009 | |
Pre B-cell acute lymphoblastic leukemia | Phase 2 | Czechia | 01 Mar 2009 | |
Pre B-cell acute lymphoblastic leukemia | Phase 2 | France | 01 Mar 2009 | |
Pre B-cell acute lymphoblastic leukemia | Phase 2 | Germany | 01 Mar 2009 | |
Pre B-cell acute lymphoblastic leukemia | Phase 2 | Italy | 01 Mar 2009 | |
Pre B-cell acute lymphoblastic leukemia | Phase 2 | United Kingdom | 01 Mar 2009 | |
Refractory T Acute Lymphoblastic Leukemia | Phase 2 | Austria | 01 Mar 2009 | |
Refractory T Acute Lymphoblastic Leukemia | Phase 2 | Czechia | 01 Mar 2009 | |
Refractory T Acute Lymphoblastic Leukemia | Phase 2 | France | 01 Mar 2009 | |
Refractory T Acute Lymphoblastic Leukemia | Phase 2 | Germany | 01 Mar 2009 |
Phase 2 | Peripheral T-Cell Lymphoma Second line | 48 | tgnindvyct(vhpiexuhwc) = nmadmvzyru hkepyrkrcf (ssaxwnqwmv, 14 - 38) View more | Positive | 01 Jan 2019 | ||
Phase 1/2 | 44 | mfzhwdrxtf(hsmakbwfpe) = oqnwvftjtg winudmiykk (oifypqblhi, 12.0 - 35.3) View more | Positive | 20 May 2016 | |||
Phase 2 | 144 | ifnlgjwmcq(idphxuisfs) = ejctjvtjsz yylugropjm (rybcnzqlkp ) View more | - | 01 Sep 2014 | |||
Phase 2 | 8 | Oral forodesine 200 mg/d | atbvyhmcqu(knmjdmujup) = vofzbjydya uhkfxxybdo (doyjpbgfsz ) View more | - | 12 Aug 2010 | ||
Not Applicable | 64 | dvcwjaqcuv(uvrxudpisu) = bsmzqrsumf zdmyqikyqh (cwcpgykqaw ) View more | - | 20 May 2009 |